Company
EpiBone
BONES and cartilage grOWN FROM stem CELLS
Also known as EpiBone, Inc.
- Status
- Operatingas of 2026-09-17
- Legal name
- EpiBone, Inc.
Record updated 28 September 2026
About
Using proven science and engineering, EpiBone is working to help people live happier and more active lives. Skeletal conditions are the #1 cause of disability worldwide, and yet still are mostly treated with a mix of pain meds and carpentry. These neither address the root causes of pain or provide long-term solutions, particularly for younger, active patients. Our technology allows us to regrow instead of replace the body, using stem cells to grow personalized bone and cartilage products. We no longer need to cut out parts of your body to cure trauma, or implant synthetic materials that begin degrading the moment they touch your body. The healing medium is not simply atoms and molecules; it is the power of life itself.
Funding snapshot
- Total raised
- $47.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4.3M2025-09-02
Funding rounds
- Round, 2025
- $4.3M2025-09-02, SEC form D sold, 131 investors
- Round, 2022
- $18.5M2022-12-12, SEC form D sold, 51 investors
- Round, 2021
- $750K2021-02-03, SEC form D sold, 4 investors
- Round, 2020
- $24.3M2020-01-23, SEC form D sold, 140 investors
Products
- Other
- personalized bone and cartilage products